GB0220197D0 - Refolding method - Google Patents

Refolding method

Info

Publication number
GB0220197D0
GB0220197D0 GBGB0220197.8A GB0220197A GB0220197D0 GB 0220197 D0 GB0220197 D0 GB 0220197D0 GB 0220197 A GB0220197 A GB 0220197A GB 0220197 D0 GB0220197 D0 GB 0220197D0
Authority
GB
United Kingdom
Prior art keywords
refolding method
refolding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0220197.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Universiteit Utrecht
Original Assignee
GlaxoSmithKline Biologicals SA
Rijksuniversiteit Utrecht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA, Rijksuniversiteit Utrecht filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB0220197.8A priority Critical patent/GB0220197D0/en
Publication of GB0220197D0 publication Critical patent/GB0220197D0/en
Priority to PCT/EP2003/008569 priority patent/WO2004015099A2/en
Priority to DE20321889U priority patent/DE20321889U1/de
Priority to TW092121011A priority patent/TWI360424B/zh
Priority to SI200332262T priority patent/SI1524993T1/sl
Priority to PT37841533T priority patent/PT1524993E/pt
Priority to KR1020127002482A priority patent/KR101239242B1/ko
Priority to RU2007127448/15A priority patent/RU2494758C2/ru
Priority to CN201210028610.3A priority patent/CN102552895B/zh
Priority to BR0313121-1A priority patent/BR0313121A/pt
Priority to US10/523,044 priority patent/US7838014B2/en
Priority to KR1020057001924A priority patent/KR20050028051A/ko
Priority to EP03784151A priority patent/EP1524991A1/en
Priority to EP10177890.0A priority patent/EP2255826B1/en
Priority to CA002489030A priority patent/CA2489030A1/en
Priority to EP03784153A priority patent/EP1524993B1/en
Priority to JP2005506111A priority patent/JP5409986B2/ja
Priority to DK10177890.0T priority patent/DK2255826T3/en
Priority to CA002493092A priority patent/CA2493092A1/en
Priority to EP03784152.5A priority patent/EP1524992B1/en
Priority to KR1020087019883A priority patent/KR101139976B1/ko
Priority to AU2003250204A priority patent/AU2003250204B8/en
Priority to ES03784152.5T priority patent/ES2537737T3/es
Priority to PL375407A priority patent/PL216662B1/pl
Priority to PCT/EP2003/008567 priority patent/WO2004014419A1/en
Priority to EP10177887A priority patent/EP2258385A3/en
Priority to DK03784153.3T priority patent/DK1524993T3/da
Priority to NZ537181A priority patent/NZ537181A/en
Priority to HUE10177890A priority patent/HUE029200T2/en
Priority to CN038186489A priority patent/CN1674933B/zh
Priority to AU2003269864A priority patent/AU2003269864A1/en
Priority to DE20321890U priority patent/DE20321890U1/de
Priority to AU2003260357A priority patent/AU2003260357B2/en
Priority to ES10177890.0T priority patent/ES2575014T3/es
Priority to JP2005506114A priority patent/JP2006506467A/ja
Priority to US10/523,117 priority patent/US20060240045A1/en
Priority to EP12157807.4A priority patent/EP2481419A3/en
Priority to CA2493124A priority patent/CA2493124C/en
Priority to BR0313100-9A priority patent/BR0313100A/pt
Priority to PT101778900T priority patent/PT2255826E/pt
Priority to NZ587398A priority patent/NZ587398A/en
Priority to NZ537904A priority patent/NZ537904A/en
Priority to MYPI20032904A priority patent/MY149591A/en
Priority to EP10177891A priority patent/EP2258386A3/en
Priority to EP08153843A priority patent/EP1961427A3/en
Priority to US10/523,114 priority patent/US20060034854A1/en
Priority to PCT/EP2003/008568 priority patent/WO2004014417A2/en
Priority to CN2012102805434A priority patent/CN103007263A/zh
Priority to PL03375408A priority patent/PL375408A1/xx
Priority to NZ552686A priority patent/NZ552686A/en
Priority to NZ574530A priority patent/NZ574530A/en
Priority to JP2005506112A priority patent/JP4740738B2/ja
Priority to CNA038184540A priority patent/CN1671413A/zh
Priority to ES03784153T priority patent/ES2408251T3/es
Priority to EP03750408A priority patent/EP1524990A2/en
Priority to EP10177881A priority patent/EP2258384A3/en
Priority to PCT/EP2003/008571 priority patent/WO2004014418A2/en
Priority to PL399492A priority patent/PL399492A1/pl
Priority to MXPA05001265A priority patent/MXPA05001265A/es
Priority to EP10177892A priority patent/EP2258387A3/en
Priority to SI200332485A priority patent/SI2255826T1/sl
Priority to JP2005506113A priority patent/JP2006500963A/ja
Priority to KR1020117004904A priority patent/KR101237329B1/ko
Priority to PL399214A priority patent/PL220107B1/pl
Priority to BRPI0313120-3A priority patent/BR0313120A/pt
Priority to AU2003253375A priority patent/AU2003253375B2/en
Priority to CA002493977A priority patent/CA2493977A1/en
Priority to KR1020057001941A priority patent/KR101140033B1/ko
Priority to MXPA05001349A priority patent/MXPA05001349A/es
Priority to US10/523,055 priority patent/US20060057160A1/en
Priority to PL03375382A priority patent/PL375382A1/xx
Priority to HK05109073.6A priority patent/HK1077014B/en
Priority to KR1020057001933A priority patent/KR20050039839A/ko
Priority to MXPA05000842A priority patent/MXPA05000842A/es
Priority to US10/525,889 priority patent/US20080025993A1/en
Priority to PCT/EP2003/010085 priority patent/WO2004020452A2/en
Priority to AU2003273854A priority patent/AU2003273854A1/en
Priority to CA002496045A priority patent/CA2496045A1/en
Priority to ES03757819.2T priority patent/ES2505692T3/es
Priority to EP03757819.2A priority patent/EP1532168B1/en
Priority to JP2004532178A priority patent/JP4652808B2/ja
Priority to IL16566004A priority patent/IL165660A0/xx
Priority to IS7593A priority patent/IS7593A/is
Priority to IS7601A priority patent/IS7601A/is
Priority to NO20050010A priority patent/NO20050010L/no
Priority to NO20050008A priority patent/NO20050008L/no
Priority to IS7658A priority patent/IS7658A/is
Priority to IL166433A priority patent/IL166433A/en
Priority to NO20050421A priority patent/NO20050421L/no
Priority to CO05007265A priority patent/CO5680454A2/es
Priority to CO05007268A priority patent/CO5680456A2/es
Priority to CO05007266A priority patent/CO5680455A2/es
Priority to AU2008202479A priority patent/AU2008202479C1/en
Priority to AU2008255270A priority patent/AU2008255270A1/en
Priority to US12/693,271 priority patent/US20100291137A1/en
Priority to JP2010226544A priority patent/JP2011057679A/ja
Priority to US12/909,621 priority patent/US8221770B2/en
Priority to JP2010237357A priority patent/JP5414651B2/ja
Priority to JP2011047056A priority patent/JP2011142916A/ja
Priority to IL213264A priority patent/IL213264A0/en
Priority to US13/248,693 priority patent/US20120027800A1/en
Priority to US13/299,007 priority patent/US20120064119A1/en
Priority to US13/299,041 priority patent/US20120064120A1/en
Priority to JP2012026928A priority patent/JP5789203B2/ja
Priority to CY20131100435T priority patent/CY1114243T1/el
Priority to LU92262C priority patent/LU92262I2/fr
Priority to CY2013036C priority patent/CY2013036I1/el
Priority to US14/844,989 priority patent/US20160082097A1/en
Priority to CY20161100532T priority patent/CY1117643T1/el
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A61K39/1045—Moraxella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB0220197.8A 2002-08-02 2002-08-30 Refolding method Ceased GB0220197D0 (en)

Priority Applications (109)

Application Number Priority Date Filing Date Title
GBGB0220197.8A GB0220197D0 (en) 2002-08-30 2002-08-30 Refolding method
PCT/EP2003/008569 WO2004015099A2 (en) 2002-08-02 2003-07-31 Vaccine composition comprising lipooligosaccharide with reduced phase variability
DE20321889U DE20321889U1 (de) 2002-08-02 2003-07-31 Impfstoffzusammensetzung
TW092121011A TWI360424B (en) 2002-08-02 2003-07-31 Vaccine
SI200332262T SI1524993T1 (sl) 2002-08-02 2003-07-31 Neisserijski vakcinski sestavki, ki obsegajo kombinacijo antigenov
PT37841533T PT1524993E (pt) 2002-08-02 2003-07-31 Composições de vacina de neisseria compreendendo uma combinação de antigénios
KR1020127002482A KR101239242B1 (ko) 2002-08-02 2003-07-31 항원 조합물을 포함하는 나이세리아 백신 조성물
RU2007127448/15A RU2494758C2 (ru) 2002-08-02 2003-07-31 Нейссериальные вакцинные композиции, содержащие комбинацию антигенов
CN201210028610.3A CN102552895B (zh) 2002-08-02 2003-07-31 疫苗组合物
BR0313121-1A BR0313121A (pt) 2002-08-02 2003-07-31 Composição imunogênica, vacina, métodos de tratamento ou prevenção de doença neisserial, de preparação da composição imunogênica, de preparação da vacina, de preparação de uma imunoglobina para uso na prevenção ou tratamento de infecção neisserial, e de tratamento ou prevenção de infecção neisserial, usos da vacina e da preparação farmacêutica, cepa neisserial geneticamente engenheirada, imunoglobina, e, composição farmacêutica
US10/523,044 US7838014B2 (en) 2002-08-02 2003-07-31 Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB- Neisseria meningitidis
KR1020057001924A KR20050028051A (ko) 2002-08-02 2003-07-31 그램 음성 박테리아로부터 유래된 트랜스페린 결합 단백질및 ｈｓｆ를 포함하는 백신 조성물
EP03784151A EP1524991A1 (en) 2002-08-02 2003-07-31 Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
EP10177890.0A EP2255826B1 (en) 2002-08-02 2003-07-31 Neisserial vaccine compositions comprising a combination of antigens
CA002489030A CA2489030A1 (en) 2002-08-02 2003-07-31 Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
EP03784153A EP1524993B1 (en) 2002-08-02 2003-07-31 Neisserial vaccine compositions comprising a combination of antigens
JP2005506111A JP5409986B2 (ja) 2002-08-02 2003-07-31 グラム陰性細菌由来のトランスフェリン結合タンパク質およびＨｓｆを含んでなるワクチン組成物
DK10177890.0T DK2255826T3 (en) 2002-08-02 2003-07-31 Neisserial vaccine compositions comprising a combination of antigens.
CA002493092A CA2493092A1 (en) 2002-08-02 2003-07-31 Neisserial vaccine compositions comprising a combination of antigens
EP03784152.5A EP1524992B1 (en) 2002-08-02 2003-07-31 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria menigitidis
KR1020087019883A KR101139976B1 (ko) 2002-08-02 2003-07-31 항원 조합물을 포함하는 나이세리아 백신 조성물
AU2003250204A AU2003250204B8 (en) 2002-08-02 2003-07-31 Neisserial vaccine compositions comprising a combination of antigens
ES03784152.5T ES2537737T3 (es) 2002-08-02 2003-07-31 Composiciones de vacuna que comprenden lipooligosacáridos de inmunotipo L2 y/o L3 de Neisseria meningitidis de IgtB
PL375407A PL216662B1 (pl) 2002-08-02 2003-07-31 Preparat immunogenny
PCT/EP2003/008567 WO2004014419A1 (en) 2002-08-02 2003-07-31 Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
EP10177887A EP2258385A3 (en) 2002-08-02 2003-07-31 Neisseria vaccine composition
DK03784153.3T DK1524993T3 (da) 2002-08-02 2003-07-31 Neisseria-vaccinesammensætning omfattende en kombination af antigener
NZ537181A NZ537181A (en) 2002-08-02 2003-07-31 Vaccine composition comprising transferrin binding protein and Hsf from gram negative bacteria
HUE10177890A HUE029200T2 (en) 2002-08-02 2003-07-31 Neisseria vaccine preparations containing a combination of antigens
CN038186489A CN1674933B (zh) 2002-08-02 2003-07-31 疫苗组合物
AU2003269864A AU2003269864A1 (en) 2002-08-02 2003-07-31 Vaccine composition comprising lipooligosaccharide with reduced phase variability
DE20321890U DE20321890U1 (de) 2002-08-02 2003-07-31 Impfstoffzusammensetzung
AU2003260357A AU2003260357B2 (en) 2002-08-02 2003-07-31 Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from lgtB- Neisseria minigitidis
ES10177890.0T ES2575014T3 (es) 2002-08-02 2003-07-31 Composiciones de vacuna contra Neisseria que comprenden una combinación de antígenos
JP2005506114A JP2006506467A (ja) 2002-08-02 2003-07-31 ワクチン組成物
US10/523,117 US20060240045A1 (en) 2002-08-02 2003-07-31 Neisserial vaccine compositions comprising a combination of antigens
EP12157807.4A EP2481419A3 (en) 2002-08-02 2003-07-31 Neisserial vaccines
CA2493124A CA2493124C (en) 2002-08-02 2003-07-31 Vaccine
BR0313100-9A BR0313100A (pt) 2002-08-02 2003-07-31 Composição imunogênica, composição imunogênica isolada, vacina, método de tratamento ou prevenção de doença bacteriana gram-negativa, uso da vacina, cepa bacteriana gram-negativa geneticamente manipulada, método para preparar a composição imunogênica, método para preparar a vacina, método de preparar uma imunoglobulina para uso na prevenção ou tratamento de infecção neisserial, preparação de imunoglobulina, preparação farmacêutica, e, uso da preparação farmacêutica
PT101778900T PT2255826E (pt) 2002-08-02 2003-07-31 Composições de vacina de neisseria compreendendo uma combinação de antigénios
NZ587398A NZ587398A (en) 2002-08-02 2003-07-31 Neisserial bleb preparations and vaccines comprising them
NZ537904A NZ537904A (en) 2002-08-02 2003-07-31 Neisserial vaccine compositions comprising a combination of antigens
MYPI20032904A MY149591A (en) 2002-08-02 2003-07-31 Vaccines comprising l2 and/or l3 los from neisseria
EP10177891A EP2258386A3 (en) 2002-08-02 2003-07-31 Neisseria Vaccine composition
EP08153843A EP1961427A3 (en) 2002-08-02 2003-07-31 Neisserial vaccine compositions comprising a combination of antigens
US10/523,114 US20060034854A1 (en) 2002-08-02 2003-07-31 Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
PCT/EP2003/008568 WO2004014417A2 (en) 2002-08-02 2003-07-31 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis
CN2012102805434A CN103007263A (zh) 2002-08-02 2003-07-31 疫苗组合物
PL03375408A PL375408A1 (en) 2002-08-02 2003-07-31 Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
NZ552686A NZ552686A (en) 2002-08-02 2003-07-31 Neisserial vaccine compositions comprising a combination of antigens
NZ574530A NZ574530A (en) 2002-08-02 2003-07-31 Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from lgtB-neisseria minigitidis
JP2005506112A JP4740738B2 (ja) 2002-08-02 2003-07-31 ワクチン
CNA038184540A CN1671413A (zh) 2002-08-02 2003-07-31 包含革兰氏阴性菌来源的运铁蛋白结合蛋白和hsf疫苗组合物
ES03784153T ES2408251T3 (es) 2002-08-02 2003-07-31 Composiciones de vacuna contra Neisseria que comprenden una combinación de antígenos
EP03750408A EP1524990A2 (en) 2002-08-02 2003-07-31 Vaccine composition comprising lipooligosaccharide with reduced phase variability
EP10177881A EP2258384A3 (en) 2002-08-02 2003-07-31 Neisseria vaccine composition
PCT/EP2003/008571 WO2004014418A2 (en) 2002-08-02 2003-07-31 Neisserial vaccine compositions comprising a combination of antigens
PL399492A PL399492A1 (pl) 2002-08-02 2003-07-31 Szczepionka
MXPA05001265A MXPA05001265A (es) 2002-08-02 2003-07-31 Composiciones de vacuna de neisserial que comprenden una combinacion de antigenos.
EP10177892A EP2258387A3 (en) 2002-08-02 2003-07-31 Neisseria vaccine composition
SI200332485A SI2255826T1 (sl) 2002-08-02 2003-07-31 Neisserijski vakcinski sestavki, ki obsegajo kombinacijo antigenov
JP2005506113A JP2006500963A (ja) 2002-08-02 2003-07-31 ワクチン組成物
KR1020117004904A KR101237329B1 (ko) 2002-08-02 2003-07-31 항원 조합물을 포함하는 나이세리아 백신 조성물
PL399214A PL220107B1 (pl) 2002-08-02 2003-07-31 Preparat immunogenny, szczepionka oraz zastosowanie tej szczepionki
BRPI0313120-3A BR0313120A (pt) 2002-08-02 2003-07-31 preparações de bleb e de los, cepa(s) neisserial/neisseriais, composição imunogênica ou vacina, e, processos de fabricação da vacina de preparação de bleb neisserial e de produção de uma preparação de bleb
AU2003253375A AU2003253375B2 (en) 2002-08-02 2003-07-31 Vaccine composition comprising transferrin binding protein and Hsf from Gram negative bacteria
CA002493977A CA2493977A1 (en) 2002-08-02 2003-07-31 Vaccine composition comprising lipooligosaccharide with reduced phase variability
KR1020057001941A KR101140033B1 (ko) 2002-08-02 2003-07-31 항원 조합물을 포함하는 나이세리아 백신 조성물
MXPA05001349A MXPA05001349A (es) 2002-08-02 2003-07-31 Composiciones de vacunas que contienen lipooligosacaridos de inmunotipo l2 y/o l3 de minigitidis neiseria lgtb.
US10/523,055 US20060057160A1 (en) 2002-08-02 2003-07-31 Vaccine composition
PL03375382A PL375382A1 (en) 2002-08-02 2003-07-31 Vaccine
HK05109073.6A HK1077014B (en) 2002-08-02 2003-07-31 Neisserial vaccine compositions comprising a combination of antigens
KR1020057001933A KR20050039839A (ko) 2002-08-02 2003-07-31 Ｌｇｔｂ- 나이세리아 메닌기티디스로부터의 ｌ2 및/또는ｌ3 면역유형 리포올리고사카라이드를 포함하는 백신 조성물
MXPA05000842A MXPA05000842A (es) 2002-08-02 2003-07-31 Composicion de vacuna que comprende proteina de enlace de transferrina y hsf de bacteria gram-negativa.
US10/525,889 US20080025993A1 (en) 2002-08-30 2003-08-28 Method for Refolding Neisserial Nspa Protein
PCT/EP2003/010085 WO2004020452A2 (en) 2002-08-30 2003-08-28 Method for refolding neisserial nspa protein
AU2003273854A AU2003273854A1 (en) 2002-08-30 2003-08-28 Method for refolding neisserial nspa protein
CA002496045A CA2496045A1 (en) 2002-08-30 2003-08-28 Method for refolding neisserial nspa protein
ES03757819.2T ES2505692T3 (es) 2002-08-30 2003-08-28 Procedimiento de replegamiento de proteína NSPA de Neisseria
EP03757819.2A EP1532168B1 (en) 2002-08-30 2003-08-28 Method for refolding neisserial nspa protein
JP2004532178A JP4652808B2 (ja) 2002-08-30 2003-08-28 ナイセリアＮｓｐＡタンパク質をリフォールディングする方法
IL16566004A IL165660A0 (en) 2002-08-02 2004-12-09 Vaccine composition comprising transferrin bindin g protein and HSF from gram negative bacteria
IS7593A IS7593A (is) 2002-08-02 2004-12-13 Bólusetningasamsetning sem samanstendur af transferrín bindi prótíni og HSF úr gram-neikvæðum bakteríum
IS7601A IS7601A (is) 2002-08-02 2004-12-16 Neisser-bóluefnasamsetningar sem innihalda blönduaf mótefnavökvum
NO20050010A NO20050010L (no) 2002-08-02 2005-01-03 Vaksineblandinger omfattende transferrin-bindende protein og HSF fra gram-negative bakterier
NO20050008A NO20050008L (no) 2002-08-02 2005-01-03 Neisserial vaksinesammensetninger omfattende en kombinasjon av antigener
IS7658A IS7658A (is) 2002-08-02 2005-01-20 Bóluefna samsetningar sem samanstanda af fitufásykrum af L2 og/eða L3 ónæmisgerð úr 1gtB mengishnettlu
IL166433A IL166433A (en) 2002-08-02 2005-01-20 Vaccine compositions comprising l2 or l3 immunotype lipooligosaccharides from lgtb neisseria menigitidis and process for their preparation
NO20050421A NO20050421L (no) 2002-08-02 2005-01-25 Vaksine
CO05007265A CO5680454A2 (es) 2002-08-02 2005-01-28 Composicion de vacuna que comprende proteina de enlace de transferrina y hsf de bacteria gram-negativa
CO05007268A CO5680456A2 (es) 2002-08-02 2005-01-28 Composiciones de vacunas que comprenden lipooligosacaridos del inmunotipo l2 y/o l3 a partir de lgtb-neisseria minigitidis
CO05007266A CO5680455A2 (es) 2002-08-02 2005-01-28 Composiciones de vacuna de neisserial que comprende una com binacion de antigenos
AU2008202479A AU2008202479C1 (en) 2002-08-02 2008-06-04 Neisserial vaccine compositions comprising a combination of antigens
AU2008255270A AU2008255270A1 (en) 2002-08-02 2008-12-12 Vaccine composition
US12/693,271 US20100291137A1 (en) 2002-08-30 2010-01-25 Method for refolding neisserial nspa protein
JP2010226544A JP2011057679A (ja) 2002-08-30 2010-10-06 ナイセリアＮｓｐＡタンパク質をリフォールディングする方法
US12/909,621 US8221770B2 (en) 2002-08-02 2010-10-21 Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis
JP2010237357A JP5414651B2 (ja) 2002-08-02 2010-10-22 ワクチン組成物
JP2011047056A JP2011142916A (ja) 2002-08-02 2011-03-04 ワクチン
IL213264A IL213264A0 (en) 2002-08-02 2011-05-31 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb neisseria minigitidis
US13/248,693 US20120027800A1 (en) 2002-08-02 2011-09-29 Neisserial vaccine compositions comprising a combination of antigens
US13/299,007 US20120064119A1 (en) 2002-08-02 2011-11-17 Neisserial vaccine compositions comprising a combination of antigens
US13/299,041 US20120064120A1 (en) 2002-08-02 2011-11-17 Neisserial vaccine compositions comprising a combination of antigens
JP2012026928A JP5789203B2 (ja) 2002-08-02 2012-02-10 ワクチン組成物
CY20131100435T CY1114243T1 (el) 2002-08-02 2013-05-31 Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
LU92262C LU92262I2 (fr) 2002-08-02 2013-07-31 Vaccin méningococcique groupe B (ADNr, composant, adsorbé) et ses dérivés pharmaceutiquement acceptables (BEXSERO)
CY2013036C CY2013036I1 (el) 2002-08-02 2013-09-05 Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
US14/844,989 US20160082097A1 (en) 2002-08-02 2015-09-03 Neisserial vaccine compositions comprising a combination of antigens
CY20161100532T CY1117643T1 (el) 2002-08-02 2016-06-15 Συνθεσεις νεϊσσεριακου εμβολιου που περιλαμβανουν συνδυασμο αντιγονων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0220197.8A GB0220197D0 (en) 2002-08-30 2002-08-30 Refolding method

Publications (1)

Publication Number Publication Date
GB0220197D0 true GB0220197D0 (en) 2002-10-09

Family

ID=9943240

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0220197.8A Ceased GB0220197D0 (en) 2002-08-02 2002-08-30 Refolding method

Country Status (8)

Country Link
US (2) US20080025993A1 (enExample)
EP (1) EP1532168B1 (enExample)
JP (2) JP4652808B2 (enExample)
AU (1) AU2003273854A1 (enExample)
CA (1) CA2496045A1 (enExample)
ES (1) ES2505692T3 (enExample)
GB (1) GB0220197D0 (enExample)
WO (1) WO2004020452A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0220197D0 (en) * 2002-08-30 2002-10-09 Univ Utrecht Refolding method
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
AU2010315115B2 (en) 2009-11-06 2015-01-29 Children's Hospital & Research Center At Oakland T-cell stimulating protein B and methods of use
US20130273607A1 (en) * 2010-10-20 2013-10-17 Medimmune, Llc Methods for processing inclusion bodies
CN104428008B (zh) 2012-05-24 2020-10-09 美国政府(由卫生和人类服务部的部长所代表) 多价脑膜炎球菌缀合物及制备缀合物的方法
EP3061296B1 (en) * 2014-02-10 2018-06-06 MediaTek Inc. Method for identifying source bss in wlan
BR102018003245A2 (pt) * 2018-02-20 2019-09-10 Fundação Oswaldo Cruz oligonucleotídeo, conjunto de oligonucleotídeos, método para detecção simultânea de neisseria meningitidis, streptococcus pneumoniae e haemophilus influenzae, e, kit.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117483A (en) * 1995-03-17 2008-03-20 Bernard Brodeur MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
DK2270173T3 (en) * 1999-05-19 2016-03-07 Glaxosmithkline Biolog Sa Neisserial combination compositions
GB9918319D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB0007432D0 (en) * 2000-03-27 2000-05-17 Microbiological Res Authority Proteins for use as carriers in conjugate vaccines
GB0220197D0 (en) * 2002-08-30 2002-10-09 Univ Utrecht Refolding method

Also Published As

Publication number Publication date
US20080025993A1 (en) 2008-01-31
WO2004020452A3 (en) 2004-08-19
US20100291137A1 (en) 2010-11-18
EP1532168A2 (en) 2005-05-25
JP2006511463A (ja) 2006-04-06
EP1532168B1 (en) 2014-07-23
ES2505692T3 (es) 2014-10-10
AU2003273854A8 (en) 2004-03-19
AU2003273854A1 (en) 2004-03-19
CA2496045A1 (en) 2004-03-11
JP2011057679A (ja) 2011-03-24
WO2004020452A2 (en) 2004-03-11
JP4652808B2 (ja) 2011-03-16

Similar Documents

Publication Publication Date Title
GB0226725D0 (en) method
GB0203306D0 (en) Method
GB0208104D0 (en) Method
GB0211975D0 (en) Method
GB0228289D0 (en) Method
AU2003258070A8 (en) Electrodionization method
GB0214209D0 (en) Method
GB0213261D0 (en) Method
GB0205509D0 (en) Method
GB0209296D0 (en) Method
AU2003273854A8 (en) Refolding method
GB0208383D0 (en) Method
GB0200865D0 (en) Method
GB0207266D0 (en) Method
GB0225236D0 (en) Method
GB0218871D0 (en) Method
GB0207167D0 (en) Method
GB0226856D0 (en) Alignmment method
GB0205864D0 (en) Method
GB0226353D0 (en) Method
GB0226281D0 (en) Method
GB0205861D0 (en) Method
GB0205469D0 (en) Method
GB0224997D0 (en) Method
GB0204114D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)